Doxycycline Hyclate Pharma Grade

Product Overview

Doxycycline Hyclate is a broad-spectrum tetracycline antibiotic with established first-line indications across respiratory, urogenital, and zoonotic infections. It demonstrates excellent oral bioavailability and a long elimination half-life enabling once or twice-daily dosing. Doxycycline is unique among tetracyclines for its predictable absorption even in the presence of food and its favorable safety profile in patients with renal impairment.

Our Doxycycline Hyclate is CEP-certified and manufactured under strict GMP conditions, meeting BP and EP pharmacopoeia standards. Its versatility makes it a cornerstone antibiotic listed on the WHO Model List of Essential Medicines for numerous indications.

Quality Specifications

Purity	As per BP/EP monograph
Residual Solvents	Compliant with ICH Q3C
Heavy Metals	Compliant with pharmacopoeia limits
GMP Status	Manufactured under GMP conditions

Pharmaceutical Applications

• Respiratory Tract Infections: Community-acquired pneumonia, bronchitis, sinusitis
• Sexually Transmitted Infections: Chlamydia trachomatis, non-gonococcal urethritis
• Dermatology: Acne vulgaris and rosacea treatment
• Malaria Prophylaxis: CDC-recommended for travelers to endemic regions
• Lyme Disease: First-line treatment for early localized and disseminated Lyme disease
• Anthrax: Post-exposure prophylaxis and treatment